CCNA2 overexpression has been reported in certain types of cancer, such as pancreatic ductal adenocarcinoma (Dong et al., 2019), stomach adenocarcinoma (Zhang et al., 2018a), and hepatocellular carcinoma (Zhang et al., 2021). The gene discussed is CCNA2; the disease is cancer.